Health & Fitness
Tue, February 1, 2011Mon, January 31, 2011Sun, January 30, 2011Fri, January 28, 2011Thu, January 27, 2011Wed, January 26, 2011Tue, January 25, 2011Mon, January 24, 2011Sun, January 23, 2011Sat, January 22, 2011Fri, January 21, 2011Thu, January 20, 2011Wed, January 19, 2011Tue, January 18, 2011Mon, January 17, 2011Fri, January 14, 2011Thu, January 13, 2011Wed, January 12, 2011Tue, January 11, 2011Mon, January 10, 2011Sun, January 9, 2011Fri, January 7, 2011Thu, January 6, 2011Wed, January 5, 2011SurModics to Webcast First Quarter Fiscal Year 2011 Earnings Conference Call January 26
//health-fitness.news-articles.net/content/2011/ .. ar-2011-earnings-conference-call-january-26.html
Published in Health and Fitness on Wednesday, January 19th 2011 at 13:05 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
EDEN PRAIRIE, Minn.--([ BUSINESS WIRE ])--SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it will host a live webcast of its first quarter 2011 conference call on Wednesday, January 26, at 4:00 p.m. CT. The Company will issue an earnings news release after the market closes that afternoon.
Gary Maharaj, chief executive officer, and Phil Ankeny, senior vice president and chief financial officer, will recap the first quarter 2011 financial results and accomplishments. To access the webcast, go to the investor relations portion of the Companya�s website at [ www.surmodics.com ] the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7:00 p.m. CT on Wednesday, January 26, until 7:00 p.m. CT on Wednesday, February 2 and can be accessed by dialing 800-406-7325 and entering conference call ID passcode 4401538. In addition, the conference call audio will be archived on the Companya�s website following the call.
About SurModics, Inc.
SurModicsa� vision is to extend and improve the lives of patients through technology innovation. The Company partners with the worlda�s foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved diagnosis and treatment for patients. Core offerings include: drug delivery technologies (coatings, microparticles, nanoparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota and its SurModics Pharmaceuticals subsidiary is located in Birmingham, Alabama. For more information about the Company, visit [ www.surmodics.com ]. The content of SurModicsa� website is not part of this release or part of any filings the Company makes with the SEC.